B+
Bull case
30%
Probability
Target price
$12.50
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
XERS
Xeris BiopharmaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Commercial momentum is supported by 34% year-over-year net product growth, 81% Recorlev growth, tighter FY2026 revenue guidance, and potential KEVEYIS IP protection through at least 2039 [#SEC-8K-2026-08-06].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +9.5.
What can break
Execution risk if Recorlev growth or FY2026 guidance delivery falls short.
Momentum
61
Value
61
Sentiment
99
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $9.50 · Bull $12.50 · Bear $7.00Analysis 2026-09-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $11.71
Why
Momentum61 · Δ7d +17.3
Value61 · Δ7d -0.0
Sentiment99 · Δ7d +9.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +9.5.
Contradictions & invalidation
- • Execution risk if Recorlev growth or FY2026 guidance delivery falls short.
- • Gvoke revenue declined 4% year over year, while SG&A and R&D expenses increased materially.
- • Gvoke revenue declined 4% year over year, SG&A increased 37%, R&D increased 32%, and Q2 net loss was $31.1 million.
Catalyst clock
2026-12-31
FY2026 revenue delivery and Recorlev execution
Lead driver: Sentiment · See AI snapshot
Momentum
61
9% active weight
Current posture
7d trendImproving
Δ7d
+17.3
Δ21d
-25.8
Value
61
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+1.2
Sentiment
99
62% active weight
Current posture
7d trendImproving
Δ7d
+9.5
Δ21d
+14.5
Why this grade
Composite grade A. Momentum 60.5 / Value 61.3 / Sentiment 98.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-09. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$7.00
Analysis reference price unavailable
Analysis 2026-09-09 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.55B
Beta
0.64
Shares Out
182.32M
P/E (TTM) · Derived
2505.9
P/S (TTM)
4.42
P/FCF (TTM)
117.94
Rev YoY
+28.7%
EPS YoY
+1387.6%
Gross Margin
+83.3%
Op Margin
+10.9%
Net Debt
$147.06M
Current Ratio
1.45
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data